Tuberculosis

Everything

Welcome to the Charles P. Felton National Tuberculosis Center
www.harlemtbcenter.org
215 West 125th Street, 1st Floor, Suite A New York, NY 10027 Featured Resource Adherence to Treatment for Latent Tuberculosis Infection: Training

Rapid Detection of rpoB Mutations in Rifampin Resistant M. tuberculosis from Sputum Samples by
www.medsci.org | 5 hours 32 minutes ago
<p><b>Objective</b>: To establish a rapid detection method for identifying <i>rpoB</i> mutations associated with rifampin (RIF) resistance in sputum specimens.</p><p><b>Methods</b>: We detected <i>rpoB</i> mutations directly in 90 sputum specimens collected from suspected tuberculosis patients

Potential New Drug Target to Fight Tuberculosis
www.dddmag.com
Innovative research at Weill Cornell Medical College suggests that Mycobacterium tuberculosis has an as yet unsuspected weakness — one that could be a prime target for drug development.

Tuberculosis (TB) vaccines reducing TB patients
www.prlog.org | Dec 14, 2009
Tuberculosis (TB) vaccines reducing TB patients. Tuberculosis is known to exist even before the year 2000BC, and writings from Egypt and Babylon mention it. Even the in the Greek literature there can be found information about physician and local doctors.

TheLancet.com
www.thelancet.com
The Lancet is the world's leading general medical journal and specialty journals in Oncology, Neurology and Infectious Diseases. Available online first. Free registration.

Bayer to support WHO and Stop TB Partnership in fighting tuberculosis | Pharma Asia
www.pharmaasia.com | Aug 16, 2011
Bayer HealthCare has agreed to support the World Health Organization (WHO) and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis (MDR-TB) by making 620,000 tablets of the antibiotic moxifloxacin available to WHO. Through the Stop TB Partnership's Global Drug Facility,

A review on various heterocyclic moieties and their antitubercular activity - EM|consulte
www.em-consulte.com
Biomedicine and pharmacotherapy - Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le mardi 28 juin 2011 - A review on various heterocyclic moieties and their antitubercular activity - EM|consulte

Tuberculosis cases reach record high - Scotsman.com News
news.scotsman.com | Jan 5, 2010
Tuberculosis cases reach record high - CASES of potentially deadly tuberculosis have soared to a record high in the Lothians, with an average of one new diagnosis every four days.<br />

Takeda Launches Initiative for Capacity Development of Health Care Workers in Africa through
www.takeda.com
March 18, 2010, Osaka, Japan – Takeda Pharmaceutical Company Limited announced today that it will launch the "Takeda Initiative," an endowment program designed to support the Global Fund to Fight AIDS, Tuberculosis and Malaria, with an aim of developing and strengthening the capacity of health care

Medical News: TB Case Finding Missing Many Patients - in Infectious Disease, Tuberculosis from
www.medpagetoday.com | Jan 14, 2011
In the era of HIV, passive case finding for tuberculosis is missing large numbers of patients, researchers reported.